Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively

NCT05050318 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza Immunization
Healthy Volunteers

Interventions

BIOLOGICAL: Fluzone Quadrivalent vaccine, No Preservative (0.5-mL dose), 2021-2022 formulation
BIOLOGICAL: Fluzone High-Dose Quadrivalent vaccine (0.7-mL dose), 2021-2022 formulation

Sponsor

Sanofi Pasteur, a Sanofi Company